Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment
Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment
Not yet recruiting · NCT06800092 · Registry updated 2026-05-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment | Fatigue, Mental Fatigue, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cancer, neoplasm | Not yet recruiting | Phase 2 / Phase 3 | 2026-05-11 | NCT06800092 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The University of Texas Medical Branch, Galveston | 59 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The University of Texas Medical Branch | Galveston | United States | 8 |